Acadia Pharmaceuticals Taps Merck HR Veteran as Chief People Officer
Event summary
- Carl Segerstrom appointed Chief People Officer at Acadia Pharmaceuticals, effective July 6, 2026.
- Segerstrom brings 25 years of HR experience, including 17 years at Merck leading global talent strategy.
- He previously managed HR for a $50+ billion business spanning 80 countries at Merck’s Human Health Division.
- Acadia focuses on neurological and rare disease therapies with FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome.
The big picture
Acadia Pharmaceuticals is bolstering its leadership team with a seasoned HR executive as it scales up its portfolio of neurological and rare disease treatments. The appointment comes amid increasing competition in the biopharmaceutical sector, where talent strategy and organizational agility are critical for sustaining innovation and market position. Segerstrom’s background in managing large, complex organizations suggests Acadia is preparing for significant growth phases.
What we're watching
- Talent Strategy Impact
- How Segerstrom’s expertise in large-scale workforce transformation will shape Acadia’s growth.
- Organizational Scaling
- Whether Acadia can sustain its expansion while maintaining a strong culture and talent pipeline.
- Digital & AI Initiatives
- The pace at which Segerstrom integrates digital and AI-enabled HR initiatives into Acadia’s operations.